Sign in

CIK 0001618835

  • Non-accelerated filer
  • Smaller reporting company

Evofem Biosciences, Inc.

Sign in to watch
Ticker
EVFM
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208527075
Phone
+1 858-550-1900
Business address
12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
Former names
Neothetics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Chief Commercial Officer bought 279 shares at $3.55 ($990)
  3. 4 Shares withheld for taxes General Counsel and Secretary gave up 17,377 shares (to pay taxes)
  4. 4 Open-market buy General Counsel and Secretary bought 5,000 shares at an average $2.21 ($11,035)
  5. 4 Open-market buy Chief Medical Officer bought 3,000 shares at $2.24 ($6,720)
  6. 4 Open-market buy Director bought 100,000 shares at an average $2.26 ($225,854)
  7. 4 Open-market buy Chief Commercial Officer bought 3,715 shares at $1.98 ($7,356)
  8. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.11 ($21,100)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,840 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Financial Officer gave up 119,510 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Executive Officer gave up 493,187 shares (to pay taxes)
  20. 4 Grant or award General Counsel and Secretary acquired 70,000 shares (grant or award)

Page 9 of 15 · 281 filings